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•	 Antimicrobial peptides are highly interesting antibiotics in multi-drug resistance infections.
•	 Antimicrobial peptides are short peptides with less than 50 amino acids and overall positive charge.
•	 First and second structural features of AMPs are important factors in their bioactivities.
•	 Cyclization and branching of AMPs could affect their pharmacokinetic and pharmacodynamics.
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ABSTRACT
Peptide and protein based therapeutics are the most promising approaches in today 
medicine. Bioactive peptides can be valuable drugs in the treatment of various illnesses, 
such as cardiovascular and neurodegenerative diseases. Cell toxic peptides can be 
considered for cancer or infection therapy. Antimicrobial peptides (AMPs) are one of the 
most interesting antibiotic groups in this regard, especially in drug resistance infections. 
Numerous	 AMPs	 have	 been	 discovered	 from	 the	 natural	 source;	 however,	 artificial	
synthetic ones have been also developed based on rational design or bioinformatics 
modeling. Physicochemical features of AMPs are highly important in their antibacterial 
activity as well as their toxicity. The best AMP is the one that has selective potent 
antimicrobial bioactivity and no or least hemolytic and cytotoxic effect. In this review, 
various structural factors affecting the AMPs bioactivity, such as AMPs size, charge, 
amphipathicity, and amino acid sequence are illustrated considering the most recently 
published articles. Finally, the trends in AMP design and development are discussed.
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Introduction 
Nowadays, multi-resistant bacterial strains are the most 
challenging issue in the treatment of infections. Several 
important species of the resistant bacteria are methicillin-
resistant  Staphylococcus  aureus (MRSA), vancomycin-
resistant  Enterococci, carbapenem-resistant  Klebsiella 
pneumonia, resistant species of Acinetobacter baumannii, 
Escherichia coli, Pseudomonas  aeruginosa, Clostridium 
difficile, and  Mycobacterium  tuberculosis (Zasloff et 
al., 2011). The emergence of this bacterial resistance 
has encouraged the search for novel antibiotics with 
improved action against hard to treat bacterial infections. 
Antimicrobial peptides (AMPs) as an evolutionarily 
conserved component of the innate immune response in 
living	organisms	are	found	to	be	an	efficient	solution	for	
DOI: http://dx.doi.org/10.22037/tpps.v1i4.16328
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Dijk et al., 2016) and wound healing activities (Mangoni 
et al., 2016; Sørensen, 2016) in addition to antimicrobial 
activity.
Methods applied for new antimicrobial peptide 
design 
Besides the discovery from natural sources, novel AMPs 
can be developed following a rational de novo design 
(Lashua et al., 2016) or mutation/conjugation approaches 
on the previously established AMP sequences (Haney 
et	 al.,	 2012;	 Jung	 et	 al.,	 2011)	 to	 improve	 specific	
antimicrobial activity and therapeutic index. 
Bioinformatics tools 
Peptides with different amino acid sequences, structures, 
and bioactivity exhibit various important roles in 
biological systems. Application of computer-based 
techniques for in silico design or development of novel 
more effective therapeutics has been progressed in the 
fields	of	peptides	and	proteins.	Databases	of	peptides	or	
proteins are the practical valuable computational tools for 
new drug design , composed of peptide sequences and 
structures with different bioactivities. There are different 
antimicrobial databases that could be applied for new 
peptide design (https://omictools.com/antimicrobial-
peptide-data-category). One of them is the Antimicrobial 
Peptide Database (APD) that is a major database of natural 
peptides with antimicrobial activity. The APD (http://aps.
resistant bacterial infections (Giuliani et al., 2007). These 
nonspecific	ancient	defense	agents	are	simple,	rapid,	and	
multifunctional mediators (Gordon et al., 2005). Various 
sequences of human natural AMPs originated from 
different cells/tissues such as cathelicidin LL-37 from the 
skin	 of	 new	 born	 infants,	 α-Defensin	 from	 neutrophils,	
and Histatin from saliva have been discovered so far 
(Wang, 2014).
Structure and amino acid sequences of AMPs have a 
wide	diversity	(Table	1),	but	as	a	general	definition,	AMPs	
are short peptides with less than 50 amino acids and 
overall positive charge, which include hydrophobic amino 
acids in balancing with charged part (Hancock, 2001). 
Regarding these properties, AMPs fold into amphipathic 
conformation upon contact with negatively charged 
bacterial membranes (Fig. 1). Traditional antibiotics 
generally	 interact	 with	 specific	 intracellular	 targets.	
Nevertheless, AMPs physically interact with the bacterial 
membrane and rapidly destroy it, then permeate to the 
cells and can destroy vital components inside the cell. 
Consequently, there are very low chances of developing 
AMP resistance by alteration of the membrane. Most 
AMPs display broad activity against both gram-positive 
and gram negative bacteria. Important challenges in 
therapeutic applications of AMPs are their low stability, 
relatively high toxicity, and high manufacturing cost (Kim 
et al., 2014). Some of these cationic peptides exhibit anti-
viral (Currie et al., 2016; Novoa et al., 2016; Methatham 
et	al.,	2017),	anti-inflammatory	(Brook	et	al.,	2016;	Lee	et	
al., 2016), immune-modulatory (Hancock et al., 2016; van 
Figure 1. Schematic representation of membrane activity as the main mechanisms for positively charged AMPs. (A) Barrel-Stave model. Vertically 
insertion of AMP molecules into the membrane. (B) Carpet model. AMP molecules surrounded small areas of the membrane by hydrophobic sides 
facing introducing pores in the membrane. (C) Toroidal pore model. Like the Barrel-stave model, peptides are assumed to adopt a trans-membrane 
orientation but AMPs are always in contact with phospholipid head groups. The blue and the red colors represent the hydrophobic and hydrophilic 
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unmc.edu/AP) can facilitate impressive search, analysis, 
design of antimicrobial peptides and, so on (Wang, 2015). 
The other is the Collection of Anti-Microbial Peptides 
(CAMP) that is a database of sequences, structures, and 
family-specific signatures of prokaryotic and eukaryotic 
AMPs (http://www.camp3.bicnirrh.res.in/index.php). 
More than 4000 AMPs collected in this dataset presented 
10247 sequences, 757 structures and 114 family-specific 
signatures of AMPs (Waghu et al., 2015). Moreover, 
DADP (Database of Anuran Defense Peptides) is another 
antimicrobial database (http://split4.pmfst.hr/dadp/?), 
which currently contains 2571 entries. For some of the 
peptides, the minimum inhibiting concentration (MIC) 
against at least one microorganism was accessible 
(Novković et al., 2012). 
Among computational approaches for design novel 
antimicrobial peptides, different strategies of structure-
activity relationship analysis could be considered 
(Blondelle and Lohner, 2010; Alvarez-Ordóñez et al., 
2013; Abraham et al., 2014). According to the results 
of such studies, some webservers provide the users 
with an ability to evaluate new peptide sequences as 
an antimicrobial agent. The dPABBs (Design Peptides 
against Bacterial Biofilms) webserver (http://ab-
openlab.csir.res.in/abp/antibiofilm/index.php) facilitates 
the prediction and design of anti-biofilm peptides. A 
prediction strategy was developed for the identification 
and optimization of novel anti-biofilm peptides providing 
features like simultaneous multi-model predictions and 
mutant generation (Sharma et al., 2016).
In addition to the biological activity, several 
other online free services provide the structural and 
conformational information. As the alpha helical structure 
of cationic AMPs and their amphipathicity are two of the 
important features of these peptides, the scientists have 
evaluated the alpha helix formation and the positions of 
hydrophobic and hydrophilic residues by Helical Wheel 
Projections from RZ Lab (http://rzlab.ucr.edu/scripts/
wheel/wheel.cgi?submit). Helical wheel is a type of 
visual representation to illustrate the characteristics of 
alpha helices in peptides and proteins (Fig. 2) (Juretić et 
al., 2017; Pedron et al., 2017).
Rational design 
Rational design of AMPs includes considering different 
prominent physicochemical aspects of formerly 
established AMPs to design and develop new peptides 
with improved antimicrobial and decreased undesirable 
properties like hemolytic activity and human cell 
cytotoxicity. The antimicrobial properties of AMPs 
depend on multiple features including their size, amino 
Figure 2. Helical Wheel presentation of Magainin II. By default, the hydrophilic residues are presented as circles, hydrophobic residues as 
diamonds, potentially negatively charged as triangles, and potentially positively charged as pentagons. The most hydrophobic residue is green, 
and the amount of green is decreasing proportionally to the hydrophobicity, with zero hydrophobicity coded as yellow. Hydrophilic residues are 
coded red with pure red being the most hydrophilic (uncharged) residue, and the amount of red decreasing proportionally to the hydrophilicity. 
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acid sequence, hydrophobicity of amino acid side-
chains, the positive charge distribution, and the structural 
conformation induced though the contact with the 
bacterial membrane (Fjell et al., 2010; Fjell et al., 2012). 
One of the strategies applied for designing novel 
AMPs is that one natural AMP sequence is considered 
as the initiation template, and then, systematic sequence 
truncation, amino acids substitution, and cyclization are 
evaluated to obtain an improved antimicrobial therapeutic 
agent. The other strategy is the study of the structure–
activity relationship (SAR), which could help scientists 
improve antimicrobial activity and selectivity (Ong et 
al., 2014). Using analytical approach, a research group 
designed a novel peptide sequence using the genetic 
algorithm. This algorithm considered the values of net 
charge, hydrophobicity, isoelectric point, and instability 
index within the specified user-established ranges to 
introduce a new antimicrobial peptide sequence. They 
designed a 17 amino acids peptide that showed promising 
MIC value for E. coli and MRSA with no hemolytic 
activity in these concentrations. Therefore, it would be a 
potential antibiotic instead of the existing ones in clinical 
use (Prada et al., 2016). 
Features considered in antimicrobial peptide 
design 
Length
Primary sequence of AMPs can affect the antimicrobial 
as well as hemolytic activity. Studies showed that AMPs 
with smaller length are less hemolytic. Several researchers 
studied how the elimination of some unessential parts of 
peptide sequences affect the toxicity and immunogenicity 
of AMPs. For instance, Zasllof et.al showed that omitting 
the three amino acids (Gly-Ile-Gly) from N- terminus of 
magainin 2 would not adversely affect the antimicrobial 
activities, but elimination of four or more residues would 
decrease the activity (Ong et al., 2014). In the design of 
new AMP sequences, the length of about 10 amino acids or 
less has been more promising than the longer sequences, 
according to the biological activity and toxicity (López-
García et al., 2002). Generally, short length antimicrobial 
peptides (natural or synthetic) are the most exciting 
ones in the pharmaceutical development, as the cost of 
production decreased and in most of cases less toxicity 
have been reported (Domalaon et al., 2016).
Charge 
As a rule, positively charged residues lead to the AMPs 
accumulation around the pathogens, through electrostatic 
interactions with membrane anionic phosphate groups. 
After achieving a critical concentration, AMPs insert 
to the lipid membrane by the hydrophobic part of their 
amphiphilic structure and result in membrane disruptions 
(Lee et al., 2016). 
Positive charge of antimicrobial peptides is one of the 
important features of AMPs affecting their bioactivity. 
Presence of Arg and Lys as the positive amino acids 
interacting with high negatively charged microbial 
membrane enhanced the antimicrobial activity. Therefore, 
these positive residues are the rational structural 
components in the design of novel AMPs influenced their 
antimicrobial activity and selectivity (Ong et al., 2014). 
In a study on AR-23 as a melittin-related peptide with 
23 residues, Zhang at al. evaluated the substitution of two 
Alanine residues and one Isoleucine residue in different 
parts of peptide, with Arg or Lys as the positively charged 
amino acids. They studied the effect of positive charge 
distribution on the antimicrobial and hemolytic activity 
of designed peptides. Lys substitution of Ile17 on the 
nonpolar face significantly reduced the hydrophobicity, 
amphipathicity, and therefore, reduced the human cells 
cytotoxicity and hemolytic activity of the peptide. 
However, substitution on the polar face slightly affected 
the peptide biophysical properties and biological activity. 
As a result, the number and position of positively charged 
residue could have effect on the biophysical properties 
and selectivity of the biological activity. Several of these 
designed peptides showed better therapeutic index as an 
antimicrobial agent for the reason that they exhibited 
similar antibacterial activity with lower cytotoxic and 
hemolytic effect compared to the parent peptide (Zhang 
et al., 2016). 
One promising example of the synthetic AMPs is 
BP100 with a short sequence of KKLFKKILKYL-NH2 
discovered through combinatorial chemistry approach. 
The first design was based on the cecropin A and melittin 
as natural AMPs. BP100 is a potent antimicrobial agent 
against Gram-negative bacteria with low cytotoxicity 
and low susceptibility to protease K degradation (Badosa 
et al., 2007). According to this peptide, a novel peptide 
library was designed in which Lys was replaced with Arg 
and Trp was added as a hydrophobic residue. R-BP100 
as Arg substituted analogue showed higher membrane-
binding affinity over BP100. RW-BP100, besides having 
Arg, also contained a Trp instead of a Tyr residue. This 
peptide exhibited higher affinity and deeper insertion into 
the membrane compared to the R-BP100. These analogues 
were also active against gram-positive bacteria that were 
the consequence of deeper insertion to the membrane, 
resulting from the Arg and Trp residues (Torcato et al., 
2013).
Conserved domains 
Peptides and proteins might contain several conserved 
domains in their primary structures involved in 
construction of active structural motives. Studies 
showed that it would be possible to find some conserved 
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domains in AMPs involved in their antimicrobial, anti-
inflammatory, or the other biological activities. Detection 
of these domains by computational methods could help 
scientists to design or improve the biological activities 
of new AMPs, such as clavanin-MO development from 
clavanin A and plant lipocalins. The newly designed AMP 
exhibited both antimicrobial and immunomodulatory 
features (Silva et al., 2016).
Hydrophobicity and hydrophilicity 
AMPs are usually cationic due to the presence of positive 
charged amino acids of lysine and arginine. Besides, they 
compose of hydrophobic residues in about fifty percent. 
Therefore, they can adopt amphipathic structures, which 
support their interactions with and penetration to cell 
membranes (Zhu et al., 2015). In general, it has been 
recognized that increasing the peptides hydrophobicity 
tends to increase their toxicity (Jiang et al., 2008; Khara 
et al., 2015). The positions of the hydrophobic side chains 
and distribution of hydrophobicity and hydrophilicity are 
considered as important factors affecting the antimicrobial, 
cytotoxic, and hemolytic activities of AMPs (Liu et al., 
2016). Some studies exerted amino acid mutation to alter 
hydrophobicity and biological activity. Murayama et al. 
showed that the amino acid substitution from leucine to 
hydrophilic glutamine at position 40 of adenovirus internal 
protein VI (AdVpVI, amino acids of 33–55) could change 
helical content but with no significant effect on their 
membrane perturbation ability. In addition, incorporation 
of phenylalanine in the hydrophobic surface exerted a 
significant effect on the membrane-binding, due to the 
shortening of helical part (Murayama et al., 2016).
Lipid chains could be considered to bind the amino 
acid structures and these lipo-amino acids (LAAs) have 
been applied in the design of novel AMP peptidomimetics. 
The LAA incorporated AMPs were an ultra-short peptide 
sequence of lysine with branches of lipid structures. This 
design could modulate the lipophilicity of the molecules. 
As a result, LAAs could combine the structural property 
of lipids and amino acids, and therefore, they would be 
easily incorporated into a peptide sequence. Some of 
the designed lipopeptides were highly effective against 
Gram-positive bacteria and MDR in addition to their low 
toxicity and high stability against trypsin degradation 
(Azmi et al., 2016).
Amino-acids modification 
Natural protease in different biological systems are one of 
the crucial cause of AMP degradation and loss of activity. 
Substitution of natural L-form amino acids with unnatural 
D-form amino acids resulted in protease resistance of 
peptide drugs, such as what have been evaluated in 
melittin, magainin, LL-37, and several others (Chen et al., 
2016). 
Substitution of D amino acids instead of L-type would 
result in a new feature to the AMPs activity or selectivity. 
Sajjan et al. demonstrated that P-113D as the mirror-
image of P-113 (a histidine-rich peptides produced by 
the salivary glands of humans and higher primates) could 
be stable and active against major pathogen of the cystic 
fibrosis patients in the presence of sputum. This amino 
acid substitution could improve the peptide stability and 
therefore, made it a suitable drug candidate for prevention 
of chronic infections in patients with cystic fibrosis 
(Sajjan, et al., 2001). In addition, D-amino acid analogues 
of hexapeptide PAF19 showed stronger antifungal 
activities (López-García et al., 2002). One another study 
investigated the incorporation of D-amino acids as the 
unnatural amino acid to the anti-mycobacterium synthetic 
peptides and confirmed that this substitution was well 
tolerated without significant alteration in toxicity profiles 
and secondary conformations (Khara et al., 2016).
The other evaluated amino acid alteration is the 
incorporation of silicon-containing amino acids 
into peptides that could change the properties of the 
biomolecules. Accordingly, this type of substitution was 
applied into hydrophobic faces of alamethicin, as an 
antimicrobial peptide. The result confirmed that these 
substitutions could improve the antimicrobial activity 
through the enhancement of membrane permeabilization 
properties (Madsen et al., 2016). 
Cyclization 
Secondary structures of AMPs, more than amino acids 
composition, play an important role in their biological 
activity. besides α-helical structures, some of natural 
AMPs exhibited the β-hairpin loop, such as defensin, 
tachyplesin, gramicidin, polyphemusin, and protegrin, 
which could exert potent antimicrobial activity only if 
constrained by disulphide bonds. Structural analysis 
of these peptides had indicated the cyclic structure 
as the prerequisite for biological activity (Vale et al., 
2014). In synthetic peptides, cyclization can enhance 
antimicrobial activity through improving membrane 
permeation (Andreev et al., 2016). Wessolowski et al. 
had developed RRWWRF-hexapeptide analogues by 
cyclization and D-amino acids substitution. In contrast 
to the D-substitution that had little influence on the 
antimicrobial activity, cyclization enhanced the activity up 
to four times (Wessolowski et al., 2004). The cyclization 
approach on the KR-12 as the short potent analogue of 
LL-37 confirmed the enhancement of biological activity 
and improvement of stability (Muhammad et al., 2016). 
Branched AMPs
G3KL as an AMP dendrimer was developed at the 
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University of Bern (Switzerland) through sequence 
optimization of an initial hit compound. This branched 
lysine-leucine peptide sequence was identified by 
screening a combinatorial library of dendrimers act as 
a membrane-disrupting agent (Stach et al., 2012). The 
developed AMP dendrimer exhibited promising activity 
against several Gram-negative strains in addition to 
the low hemolytic activity and good stability in human 
serum (Stach et al., 2014). G3KL was also evaluated as a 
novel promising antibacterial agent against drug-resistant 
Acinetobacter baumannii and Pseudomonas aeruginosa 
(Pires et al., 2015). In another novel approach, star-shaped 
peptide polymer nanoparticles had been synthesized 
consisting of lysine and valine residues. This structure 
was termed	 ʺstructurally nano-engineered antimicrobial 
peptide polymers″	or SNAPPs. The results showed that 
SNAPPs could be a low toxic and potent antimicrobial 
agent against MDR Gram-negative bacteria (Lam et al., 
2016).
Future trends 
The new approach for novel AMP development is the 
combined approach of bioinformatics and rational design. 
In this regard, Pearson et al. developed new AMP based 
on the data from both natural peptides as well as artificial 
peptides identified by screening of large randomly 
libraries. They combined de novo approach with rational 
design, and in silico modeling to design potent AMPs 
against Mycobacterium tuberculosis (Pearson et al., 2016). 
The trend in the development of novel antimicrobial 
peptide with improved activity and reduced toxicity is to 
design short cationic peptides with α-helical structure that 
compose several hydrophobic amino acids such as Trp. 
The cationic residues help the peptide to interact more 
specifically to bacterial membranes and the hydrophobic 
residues insert into the lipid bilayers of cell membrane 
and disturb the membrane and cell integrity. In addition, 
conjugation of AMPs to the nanostructures is another 
interesting approach in the development of new antibiotic 
peptide based drugs. 
AMPs were also evaluated as a drug delivery vehicle 
for Antisense peptide nucleic acid (PNA) oligomers. 
Recent study had approved that AMPs with the membrane 
incorporation properties as the mode of action could be 
an efficient carrier for bacterial delivery of the PNAs 
targeting bacterial genes (Hansen et al., 2016). Therefore, 
the scientists could focus on the development of novel 
AMPs with selective binding to the target pathogens, 
which would be considered as a drug-targeting agent in 
addition to their therapeutic importance as an antibiotic. 
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